Russia Registers Second Covid-19 Vaccine EpiVakKorona

Пятница, 16 Окт, 2020

Meanwhile, an ambitious worldwide project to deliver coronavirus vaccines to the world's poorest people, called Covax, is facing potential shortages of money, cargo planes, refrigeration and vaccines themselves.

This is not the only occasion a Covid-19 vaccine trial has been paused for safety concerns.

The goal of the agencies involved in the program, including the CDC, is to produce and deliver 300 million doses of vaccines, with the initial immunizations being made available by January 2021.

Russia's first vaccine, Sputnik V, was developed by the Moscow-based Gamaleya Institute and approved by the government on August 11, after early trials among 76 volunteers were completed.

SII is conducting phase III trials of Oxford-Astrazeneca's COVID-19 vaccine across 17 sites in India.

Union Health Minister Harsh Vardhan said on Tuesday said that India is expected to have a COVID-19 vaccine from more than one source by early next year and the government is formulating distribution strategies for the immunisation of people across the country.

Fauci also spoke about the ongoing vaccine trials and the chances of getting more cases after Labor Day, saying as one region in the country gets it under control, another hot spot can emerge.

"We need to increase production of the first and second vaccine", Putin said in comments broadcast on state TV.

"The Novosibirsk-based Vektor Centre has registered a second coronavirus vaccine, EpiVacCorona.As far as I am aware, a third vaccine is nearly ready at the Chumakov Centre of the Russian Academy of Sciences", he said.

Russian Federation has granted regulatory approval to a second COVID-19 vaccine, according to its register of authorised medicines.

Health authorities in Russian Federation have granted approval to a second Covid-19 vaccine developed by the Vector State Virology and Biotechnology Center in Siberia. A trial involving 40,000 participants is now under way in Moscow.

Globally, 42 vaccines are undergoing human trials right now, with another 151 in the pre-clinical stage. It's also not clear if the volunteer had received the vaccine or the placebo.

The company has tied up with Indian Council of Medical Research to develop a coronavirus vaccine. Phase II trials will begin on 19 October. It also plans to remove videos that say a COVID-19 vaccine will kill someone, make them infertile or that it will be a way for governments to implant chips in people.